Mitogen-activated protein kinases as glucose transducers for diabetic complications

Diabetologia

Volumn 42, Issue 11, 1999, Pages 1271-1281

  Tomlinson, D R ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Aldose reductase; ERK; Hyperglycaemia; JNK; MAP kinase; Nephropathy; Neuropathy; p38; Protein kinase C; Retinopathy

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE; GLUCOSE TRANSPORTER; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; SORBITOL;

DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; ENZYME BINDING; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; REVIEW;

ANIMALS; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; GLUCOSE; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; OXIDATIVE STRESS; PROTEIN KINASE C; SORBITOL;

EID: 0032728365     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051439     Document Type: Review

References (140)

1. 1. Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 329: 977-986
2. 2. Pirart J (1977) Diabete et complictions degeneratives presentation d'une etude prospective portant sur 4400 cas observes entre 1949-1973. Diabetes Metab 3: 97-107
3. 3. Pirart J (1978) Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Part 2. Diabetes Care 1: 252-263
4. 4. Pirart J (1978) Diabetes mellitus and its degenerative complications; a prospective study of 4400 patients observed between 1947 and 1973. Part 1. Diabetes Care 1: 168-188
5. 5. Yabe-Nishimura C (1998) Aldose reductase in glucose toxicity: A potential target for the prevention of diabetic complications. Pharmacological Reviews 50: 21-33
6. 6. Tomlinson DR (1993) Aldose reductase inhibitors and the complications of diabetes mellitus. Diabet Med 10: 214-230
7. 7. Dvornik D (1987) Aldose reductase inhibition. Biomedical Information Corporation McGraw-Hill, New York
8. 8. Hamada Y, Araki N, Koh N, Nakamura J, Horiuchi S, Hotta N (1996) Rapid formation of advanced glycation end products by intermediate metabolites of glycolytic pathway and polyol pathway. Biochem Biophys Res Commun 228: 539-543
9. 9. Brownlee M (1995) The pathological implications of protein glycation. Clin Invest Med 18: 275-281
10. 10. McCance DR, Dyer DG, Dunn JA et al. (1993) Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 91: 2470-2478
11. 11. Rittner HL, Hafner V, Klimiuk PA, Szweda LI, Goronzy JJ, Weyand CM (1999) Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis. J Clin Invest 103: 1007-1013
12. 12. Bravi MC, Pietrangeli P, Laurenti O et al. (1997) Polyol pathway activation and glutathione redox status in non-insulin-dependent diabetic patients. Metabolism 46: 1194-1198
13. 13. Phillips SA, Mirrlees D, Thornalley PJ (1993) Modification of the glyoxalase system in streptozotocin-induced diabetic rats. Effect of the aldose reductase inhibitor Statil. Biochem Pharmacol 46: 805-811
14. 14. Galle J, Schneider R, Winner B et al. (1998) Glyc-oxidized LDL impair endothelial function more potently than oxidized LDL: role of enhanced oxidative stress. Atherosclerosis 138: 65-77
15. ras -dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 272: 17810-17814
16. 16. Soulis-Liparota T, Cooper ME, Dunlop M, Jerums G (1995) The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat. Diabetologia 38: 387-394
17. 17. Baker JR, Zyzak DV, Thorpe SR, Baynes JW (1994) Chemistry of the fructosamine assay: D-glucosone is the product of oxidation of Amadori compounds. Clin Chem 40: 1950-1955
18. 18. Fu MX, Wells-Knecht KJ, Blackledge JA, Lyons TJ, Thorpe SR, Baynes JW (1994) Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes 43: 676-683
19. 19. Le Guen CA, Jones AF, Barnett AH, Lunec J (1992) Role of reactive oxygen species in the generation of fluorescence by glycation. Ann Clin Biochem 29: 184-189
20. 20. Ip YT, Davis RJ (1998) Signal transduction by the c-Jun N-terminal kinase (JNK) - from inflammation to development. Curr Opin Cell Biol 10: 205-219
21. 21. Wang XS, Diener K, Manthey CL et al. (1997) Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. J Biol Chem 272: 23668-23674
22. 22. Davis RJ (1995) Transcriptional regulation by MAP kinases. Mol Reprod Dev 42: 459-467
23. 23. Su B, Karin M (1996) Mitogen-activated protein kinase cascades and regulation of gene expression. Curr Opin Immunol 8: 402-411
24. 24. Garrington TP, Johnson GL (1999) Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol 11: 211-218
25. 25. Han J, Lee JD, Bibbs L, Ulevitch RJ (1994) A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265: 808-811
26. 26. Raingeaud J, Gupta S, Rogers JS et al. (1995) Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270: 7420-7426
27. 27. Guyton KZ, Liu Y, Gorospe M, Xu Q, Holbrook NJ (1996) Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J Biol Chem 271: 4138-4142
28. 28. Liu Y, Guyton KZ, Gorospe M, Xu Q, Lee JC, Holbrook NJ (1996) Differential activation of ERK, JNK/SAPK and P38/CSBP/RK map kinase family members during the cellular response to arsenite. Free Radic Biol Med 21: 771-781
29. 29. Price MA, Cruzalegui FH, Treisman R (1996) The p38 and ERK MAP kinase pathways cooperate to activate Ternary Complex Factors and c-fos transcription in response to UV light. EMBO J 15: 6552-6563
30. 30. Berl T, Siriwardana G, Ao L, Butterfield LM, Heasley LE (1997) Multiple mitogen-activated protein kinases are regulated by hyperosmolality in mouse IMCD cells. Am J Physiol 272: F305-F311
31. 31. Cowley S, Paterson H, Kemp P, Marshall CJ (1994) Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77: 841-852
32. 32. Lu G, Beuerman RW, Zhao S et al. (1997) Tumor necrosis factor-alpha and interleukin-1 induce activation of MAP kinase and SAP kinase in human neuroma fibroblasts. Neurochem Int 30: 401-410
33. 33. Dent P, Jarvis WD, Birrer MJ, Fisher PB, Schmidt-Ullrich RK, Grant S (1998) The roles of signaling by the p42/ p44 mitogen-activated protein (MAP) kinase pathway; a potential route to radio-and chemo-sensitization of tumor cells resulting in the induction of apoptosis and loss of clonogenicity. Leukemia 12: 1843-1850
34. 34. Bagnasco SM, Balaban R, Fales HM, Yang Y-M, Burg M (1986) Predominant osmotically active solutes in rat and rabbit renal medullas. J Biol Chem 261: 5872-5877
35. 35. Smardo FL, Jr., Burg MB, Garcia-Perez A (1992) Kidney aldose reductase gene transcription is osmotically regulated. Am J Physiol 262:C776-C782
36. 36. Edmands S, Yancey PH (1992) Effects on rat renal osmolytes of extended treatment with an aldose reductase inhibitor. Comp Biochem Physiol C103: 499-502
37. B-crystallin, and organic osmolytes in the retinal pigment epithelium. Invest Ophthalmol Vis Sci 34: 2352-2359
38. 38. Stevens MJ, Lattimer SA, Kamijo M, Van Huysen C, Sima AAF, Greene DA (1993) Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat. Diabetologia 36: 608-614
39. 39. Bondy CA, Lightman SL (1989) Developmental and physiological pattern of aldose reductase mRNA expression in lens and retina. Mol Endocrinol 3: 1417-1425
40. 40. Iwata T, Sato S, Jimenez J et al. (1999) Osmotic response element is required for the induction of aldose reductase by tumor necrosis factor-a. J Biol Chem 274: 7993-8001
41. 41. Xiong H, Cheng HM (1989) Aqueous/vitreous tonicity in "sugar" cataracts. Ophthalmic Res 21: 292-296
42. +/myo-inositol transporters, aldose reductase and sorbitol dehydrogenase in macula densa cells of the kidney. Pflugers Arch 436: 807-809
43. -/betaine transporter mRNAs in individual cells of the kidney during changes in the diuretic state. Pflugers Arch 437: 248-254
44. 44. Posas F, Wurgler MS, Maeda T, Witten EA, Thai TC, Saito H (1996) Yeast HOG1 MAP kinase cascade is regulated by a multistep phosphorelay mechanism in the SLN1-YPD1-SSK1 "two-component" osmosensor. Cell 86: 865-875
45. 45. Maeda T, Takekawa M, Saito H (1995) Activation of yeast PBS2 MAPKK by MAPKKKs or by binding of an SH3-containing osmosensor. Science 269: 554-558
46. 46. Maeda T, Wurgler MS, Saito H (1994) A two-component system that regulates an osmosensing MAP kinase cascade in yeast. Nature 369: 242-245
47. 47. Sheikh-Hamad D, Di Mari J, Suki WN, Safirstein R, Watts BA3, Rouse D (1998) p38 kinase activity is essential for osmotic induction of mRNAs for HSP70 and transporter for organic solute betaine in Madin-Darby canine kidney cells. J Biol Chem 273: 1832-1837
48. 48. Kultz D, Garcia-Perez A, Ferraris JD, Burg MB (1997) Distinct regulation of osmoprotective genes in yeast and mammals. Aldose reductase osmotic response element is induced independent of p38 and stress-activated protein kinase/Jun N-terminal kinase in rabbit kidney cells. J Biol Chem 272: 13165-13170
49. 49. Finegold D, Lattimer SA, Nolle S, Bernstein M, Greene DA (1983) Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy. Diabetes 32: 988-992
50. 50. Mayer JH, Tomlinson DR (1983) Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Diabetologia 25: 433-438
51. 51. Cohen MP (1986) Aldose reductase, glomerular metabolism, and diabetic nephropathy. Metabolism 35: 55-59
52. 52. Cohen MP, Klepser H (1988) Glomerular Na + -K + -AT-Pase activity in acute and chronic diabetes and with aldose reductase inhibition. Diabetes 37: 558-562
53. 53. MacGregor LC, Rosecan LR, Laties AM, Matschinsky FM (1986) Altered Retinal Metabolism in Diabetes I. Microanalysis of lipid, glucose, sorbitol and myo-inositol in the choroid and in the individual layers of the rabbit retina. J Biol Chem 261: 4046-4051
54. 54. Li WY, Zhou Q, Tang L, Qin M, Hu TS (1990) Intramural pericyte degeneration in early diabetic retinopathy study in vitro. Chin Med J (Engl) 103: 7-13
55. 55. Kern TS, Engerman RL (1991) Retinal polyol and myo-inositol in galactosemic dogs given an aldose-reductase inhibitor. Invest Ophthalmol Vis Sci 32: 3175-3177
56. 56. Nakanishi T, Uyama O, Sugita M (1991) Osmotically regulated taurine content in rat renal inner medulla. Am J Physiol 261:F957-F962
57. 57. Nakanishi T, Yamauchi A, Sugita M, Takamitsu Y (1996) Aldose reductase and myo-inositol transporter mRNA are independently regulated in rat renal medulla. J Am Soc Nephrol 7: 283-289
58. 58. Yue DK, Delbridge L, Handelsmann DJ, Reeve T, Turtle JR (1983) The thermal stability of collagen in diabetic rats: correlation with severity of diabetes and non-enzymatic glycosylation. Diabetologia 24: 282-285
59. 59. Nicholls K, Mandel TE (1989) Advanced glycosylation end-products in experimental murine diabetic nephropathy: effect of islet isografting and of aminoguanidine. Lab Invest 60: 486-491
60. 60. Ellis EN, Good BH (1991) Prevention of glomerular basement membrane thickening by aminoguanidine in experimental diabetes mellitus. Metabolism 40: 1016-1019
61. 61. McLean WG (1997) The role of the axonal cytoskeleton in diabetic neuropathy. Neurochem Res 22: 951-956
62. 62. Ryle C, Donaghy M (1995) Non-enzymatic glycation of peripheral nerve proteins in human diabetics. J Neurol Sci 129: 62-68
63. 63. Federoff HJ, Lawrence D, Brownlee M (1993) Nonenzymatic glycosylation of laminin and the laminin peptide CI-KVAVS inhibits neurite outgrowth. Diabetes 42: 509-513
64. 64. Simm A, Munch G, Seif F et al. (1997) Advanced glycation endproducts stimulate the MAP-kinase pathway in tubulus cell line LLC-PK1. FEBS Lett 410: 481-484
65. 65. Thornalley PJ (1998) Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. Cell Mol Neurobiol 44: 1013-1023
66. 66. Wallace DJ (1977) The biology of aging: 1976, an overview. J Am Geriatr Soc 25: 104-111
67. 67. Van Dam PS, Bravenboer B (1997) Oxidative stress and antioxidant treatment in diabetic neuropathy. Neurosci Res Commun 21: 41-48
68. 68. Packer L, Witt EH, Tritschler HJ (1995) a-Lipoic acid as a biological antioxidant. Free Radic Biol Med 19: 227-250
69. 69. Tesfamariam B (1994) Free radicals in diabetic endothelial cell dysfunction. Free Radic Biol Med 16: 383-391
70. 70. Wolff SP, Jiang ZY, Hunt JV (1991) Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med 10: 339-352
71. 71. Nishigaki I, Hagihara M, Tsunekawa T, Masaki M, Yagi K (1981) Lipid peroxide level of serum lipoprotein fractions of diabetic patients. Biochem Med 25: 373-378
72. 72. Gallou G, Ruelland A, Legras B, Maugendre D, Allannic H, Cloarec L (1993) Plasma malondialdehyde in type 1 and type 2 diabetic patients. Clin Chim Acta 214: 227-234
73. 73. Lung C, Pinnas JL, Danial Yahya M, Meinke GC, Mooradian AD (1993) Malondialdehyde modified proteins and their antibodies in the plasma of control and streptozotocin induced diabetic rats. Life Sci 52: 329-337
74. 74. Baynes JW (1994) AGEing growth factors: A role in diabetic vascular disease. J Clin Invest 94: 2
75. 75. Ross WM, Creighton MO, Stewart-DeHann PJ, Sanwal M, Hirst M, Trevithick JR (1982) Modelling cortical cataractogenesis. III. In vitro effects of vitamin E on cataractogenesis in diabetic rats. Can J Ophthalmol 17: 61-66
76. 76. Morel DW, Chisolm GM (1989) Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J Lipid Res 30: 1827-1834
77. 77. Srivastava SK, Ansari NH, Liu S et al. (1989) The effect of oxidants on biomembranes and cellular metabolism. Mol Cell Biochem 91: 149-157
78. 78. Kunisaki M, Umeda F, Inoguchi T, Watanabe J, Nawata H (1990) Effect of vitamin E administration on platelet function in diabetes mellitus. Diabetes Res Clin Pract 14: 37-42
79. 79. Young IS, Torney JJ, Trimble ER (1992) The effect of ascorbate supplementation on oxidative stress in the streptozotocin diabetic rat. Free Radic Biol Med 13: 41-46
80. 80. Cameron NE, Cotter MA, Maxfield EK (1993) Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats. Diabetologia 36: 299-304
81. 81. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA (1996) Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 97: 22-28
82. 82. Rösen P, Du XL, Tschöpe D (1998) Role of oxygen derived radicals for vascular dysfunction in the diabetic heart: Prevention by a-tocopherol? Mol Cell Biochem 188: 103-111
83. 83. Sachse G, Willms B (1980) Efficacy of thioctic acid in the therapy of peripheral diabetic neuropathy. Horm Metab Res Suppl 9: 105-107
84. 84. Ziegler D, Hanefeld M, Ruhnau KJ et al. (1995) Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant a-lipoic acid - A 3-week multicentre randomized controlled trial (ALADIN study). Diabetologia 38: 1425-1433
85. 85. Ziegler D, Gries FA (1997) a-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy. Diabetes 46:S62-S66
86. 86. Mendelson KG, Contois LR, Tevosian SG, Davis RJ, Paulson KE (1996) Independent regulation of JNK/ p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver. Proc Natl Acad Sci U S A 93: 12908-12913
87. 87. Huot J, Houle F, Marceau F, Landry J (1997) Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ Res 80: 383-392
88. 88. Numazawa S, Yamada H, Furusho A, Nakahara T, Oguro T, Yoshida T (1997) Cooperative induction of c-fos and heme oxygenase gene products under oxidative stress in human fibroblastic cells. Exp Cell Res 237: 434-444
89. 89. Yu R, Tan TH, Kong AT (1997) Butylated hydroxyanisole and its metabolite tert-butylhydroquinone differentially regulate mitogen-activated protein kinases. The role of oxidative stress in the activation of mitogen-activated protein kinases by phenolic antioxidants. J Biol Chem 272: 28962-28970
90. 90. Clerk A, Michael A, Sugden PH (1998) Stimulation of multiple mitogen-activated protein kinase sub-families by oxidative stress and phosphorylation of the small heat shock protein, HSP25/27, in neonatal ventricular myocytes. Biochem J 333: 581-589
91. 91. Kong ANT, Yu R, Lei W, Mandlekar S, Tan TH, Ucker DS (1998) Differential activation of MAPK and ICE/ Ced-3 protease in chemical-induced apoptosis - The role of oxidative stress in the regulation of mitogen-activated protein kinases (MAPKs) leading to gene expression and survival or activation of caspases leading to apoptosis. Restorative Neurol Neurosci 12: 63-70
92. 92. Wang XT, Martindale JL, Liu YS, Holbrook NJ (1998) The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem J 333: 291-300
93. 93. Gonzalez A-M, Sochor M, McLean P (1983) The effect of an aldose reductase inhibitor (sorbinil) on the level of metabolites in lenses of diabetic rats. Diabetes 32: 482-485
94. 94. De Mattia G, Laurenti O, Bravi C, Ghiselli A, Iuliano L, Balsano F (1994) Effect of aldose reductase inhibition on glutathione redox status in erythrocytes of diabetic patients. Metabolism 43: 965-968
95. 95. Adler V, Schaffer A, Kim J, Dolan L, Ronai Z (1995) UV irradiation and heat shock mediate JNK activation via alternate pathways. J Biol Chem 270: 26071-26077
96. 96. Fernyhough P, Gallagher A, Averill S, Priestley JV, Hounsom L, Tomlinson DR (1999) Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes 48: 881-889
97. 97. Hounsom L, Horrobin DF, Tritschler H, Corder R, Tomlinson DR (1998) A lipoic acid-gamma linolenic acid congugate is effective against multiple indices of experimental diabetic neuropathy. Diabetologia 41: 839-843
98. 98. Craven PA, De Rubertis FR (1989) Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose. J Clin Invest 83: 1667-1675
99. 99. Lee T-S, Saltsman KA, Ohashi H, King GL (1989) Activation of protein kinase C by elevation of glucose concentration: Proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci USA 86: 5141-5145
100. 100. Shiba T, Inoguchi T, Sportsman JR, Heath WF, Bursell S, King GL (1993) Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am J Physiol 265:E783-E793
101. 101. Kunisaki M, Bursell S-E, Umeda F, Nawata H, King GL (1994) Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels. Diabetes 43: 1372-1377
102. 102. Kunisaki M, Bursell S-E, Clermont AC et al. (1995) Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. Am J Physiol 269:E239-E246
103. 103. Doanes AM, Hegland DD, Sethi R, Kovesdi I, Bruder JT, Finkel T (1999) VEGF stimulates MAPK through a pathway that is unique for receptor tyrosine kinases. Biochem Biophys Res Commun 255: 545-548
104. 104. Haneda M, Araki S, Togawa M, Sugimoto T, Isono M, Kikkawa R (1997) Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 46: 847-853
105. 105. Keogh RJ, Dunlop ME, Larkins RG (1997) Effect of inhibition of aldose reductase on glucose flux, diacylglycerol formation, protein kinase C, and phospholipase A2 activation. Metabolism 46: 41-47
106. 106. Ishii H, Tada H, Isogai S (1998) An aldose reductase inhibitor prevents glucose-induced increase in transforming growth factor-b and protein kinase C activity in cultured human mesangial cells. Diabetologia 41: 362-364
107. 107. Haneda M, Kikkawa R, Sugimoto T et al. (1995) Abnormalities in protein kinase C and MAP kinase cascade in mesangial cells cultured under high glucose conditions. J Diabetes Complications 9: 246-248
108. 108. Wood KW, Sarnecki C, Roberts TM, Blenis J (1992) ras Mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK. Cell 68: 1041-1050
109. 109. Bursell SE, Takagi C, Clermont AC et al. (1997) Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats. Invest Ophthalmol Vis Sci 38: 2711-2720
110. 110. Borghini I, Ania-Lahuerta A, Regazzi R et al. (1994) a, bI, bII, d, and e protein kinase C isoforms and compound activity in the sciatic nerve of normal and diabetic rats. J Neurochem 62: 686-696
111. 111. Rowe-Rendleman CL, Eichberg J (1994) P0 phosphorylation in nerves from normal and diabetic rats: Role of protein kinase C and turnover of phosphate groups. Neurochem Res 19: 1023-1031
112. 112. Mathew J, Bianchi R, McLean WG et al. (1997) Phosphoinositide metabolism, Na,K-ATPase and protein kinase C are altered in peripheral nerve from Zucker diabetic fatty rats (ZDF/Gmi-fa). Neurosci Res Commun 20: 21-30
113. 113. Roberts RE, McLean WG (1997) Protein kinase C isozyme expression in sciatic nerves and spinal cords of experimentally diabetic rats. Brain Research 754: 147-156
114. 114. Tuck RR, Schmelzer JD, Low PA (1984) Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 107: 935-950
115. 115. Dyck PJ, Karnes JL, O'Brien PC, Okazaki H, Lais A, Engelstad JK (1986) The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann Neurol 19: 440-449
116. 116. Cameron NE, Cotter MA, Low PA (1991) Nerve blood flow in early experimental diabetes in rats: Relation to conduction deficits. Am J Physiol 261: E1-E8
117. 117. Thomas PK, Tomlinson DR (1992) Diabetic and hypoglycaemic neuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (eds) Peripheral neuropathy. W.B. Saunders Co., Philadelphia, London, Toronto, Montreal, Sydney, Tokyo, pp. 1219-1250
118. 118. Nukada H (1986) Increased susceptibility to ischemic damage in streptozocin-diabetic nerve. Diabetes 35: 1058-1061
119. 119. Fukunaga K, Miyamoto E (1998) Role of MAP kinase in neurons. Mol Neurobiol 16: 79-95
120. 120. Derkinderen P, Enslen H, Girault JA (1999) The ERK/ MAP-kinases cascade in the nervous system. Neuroreport 10:R24-R34
121. 121. Gómez N, Cohen P (1991) Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases. Nature 353: 170-173
122. 122. Volonté C, Angelastro JM, Greene LA (1993) Association of protein kinases ERK1 and ERK2 with p75 nerve growth factor receptors. J Biol Chem 268: 21410-21415
123. 123. Thomas SM, DeMarco M, D'Arcangelo G, Halegoua S, Brugge JS (1992) Ras is essential for nerve growth factor-and phorbol ester-induced tyrosine phosphorylation of MAP kinases. Cell 68: 1031-1040
124. 124. Minden A, Lin A, McMahon M et al. (1994) Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266: 1719-1723
125. 125. Hirsch DD, Stork PJ (1997) Mitogen-activated protein kinase phosphatases inactivate stress-activated protein kinase pathways in vivo. J Biol Chem 272: 4568-4575
126. 126. Lannuzel A, Barnier JV, Hery C et al. (1997) Human immunodeficiency virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neurons. Ann Neurol 42: 847-856
127. 127. Kaplan DR, Stephens RM (1994) Neurotrophin signal transduction by the Trk receptor. J Neurobiol 25: 1404-1417
128. 128. Kaplan DR, Miller FD (1997) Signal transduction by the neurotrophin receptors. Curr Opin Cell Biol 9: 213-221
129. 129. Casaccia-Bonnefil P, Kong HY, Chao MV (1998) Neurotrophins: the biological paradox of survival factors eliciting apoptosis. Cell Death Differentiation 5: 357-364
130. 130. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV (1996) Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383: 716-719
131. 131. Aloyz RS, Bamji SX, Pozniak CD et al. (1998) P53 is essential for developmental neuron death as regulated by the TrkA and p75 neurotrophin receptors. J Cell Biol 143: 1691-1703
132. 132. Ladiwala U, Lachance C, Simoneau SJJ, Bhakar A, Barker PA, Antel JP (1998) p75 neurotrophin receptor expression on adult human oligodendrocytes: Signaling without cell death in response to NGF. J Neurosci 18: 1297-1304
133. 133. Jakobsen J, Brimijoin S, Skau K, Sidenius P, Wells D (1981) Retrograde axonal transport of transmitter enzymes, fucose-labeled protein, and nerve growth factor in streptozotocin-diabetic rats. Diabetes 30: 797-803
134. 125I]nerve growth factor in ileal mesenteric nerves in vitro: effect of streptozotocin diabetes. Brain Res 378: 325-336
135. 135. Fernyhough P, Diemel LT, Hardy J, Brewster WJ, Mohiuddin L, Tomlinson DR (1995) Human recombinant nerve growth factor replaces deficient neurotrophic support in the diabetic rat. Eur J Neurosci 7: 1107-1110
136. NTR gene expression in lumbar dorsal root ganglia of streptozocin-induced diabetic rats. Diabetes 47: 1779-1785
137. NGFR. Mol Brain Res 37: 166-174
138. 138. Boulton TG, Nye SH, Robbins DJ et al. (1991) ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65: 663-675
139. 139. Schmidt RE, Beaudet LN, Plurad SB, Dorsey DA (1997) Axonal cytoskeletal pathology in aged and diabetic human sympathetic autonomic ganglia. Brain Research 769: 375-383
140. 140. Schmidt RE, Dorsey D, Parvin CA, Beaudet LN, Plurad SB, Roth KA (1997) Dystrophic axonal swellings develop as a function of age and diabetes in human dorsal root ganglia. J Neuropath Exp Neurol 56: 1028-1043